scanX

Strides Pharma Science

865.60
-34.05
(-3.78%)
Market Cap
7,977.60 Cr
EPS
-7.76
PE Ratio
23.61
Dividend Yield
0.44 %
Industry
Healthcare
52 Week High
1,675.00
52 Week Low
394.62
PB Ratio
3.25
Debt to Equity
1.28
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,667.20
#1 4,00,017.13
35.07
#1 49,887.20
12.06
#1 9,648
-18.99
44.96
Divis Laboratories
6,856.50
1,82,018.53
82.53
8,184.00
0.89
1,600
23.05
66.42
Cipla
1,515.70
1,22,424.28
23.63
28,409.50
7.12
5,291
30.28
55.73
Torrent Pharmaceuticals
3,416.70
1,15,636.65
59.85
10,785.70
11.59
1,656
10.91
71.04
Dr Reddys Laboratories
1,276.80
1,06,558.04
#1 18.94
28,905.40
12.36
5,578
21.14
44.33
Zydus Life Science
1,002.50
1,00,874.96
21.32
19,831.50
13.82
3,831
-0.19
73.16
Mankind Pharma
2,287.00
94,391.06
48.26
10,615.60
19.57
1,942
-10.91
35.59
Lupin
1,960.90
89,553.41
26.97
20,141.50
#1 19.94
1,936
#1 112.49
48.59
Abbott
34,665.00
73,660.71
53.54
6,097.20
10.80
1,201
27.83
68.86
Aurobindo Pharma
1,132.50
65,775.78
19.08
29,559.20
17.55
3,169
-0.50
48.07

Automatic Screeners on ScanX

Community
Support 1 Breached
Community
Support 2 Breached
Forecast
Actual
Growth Rate
Revenue Growth
8.26 %
Net Income Growth
-35.69 %
Cash Flow Change
1,478.63 %
ROE
-32.55 %
ROCE
-1,066.67 %
EBITDA Margin (Avg.)
39.00 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
314
613
729
856
980
815
931
897
802
692
791
805
1,266
478
530
862
662
696
842
760
641
839
834
845
922
702
744
805
952
954
954
933
1,014
939
1,035
1,075
1,030
1,100
1,195
1,160
1,206
Expenses
274
564
628
728
855
676
730
602
577
595
688
627
604
448
496
516
572
612
610
574
772
648
662
712
773
850
818
833
944
1,002
844
892
879
802
1,054
886
888
886
987
946
1,000
EBITDA
40
50
101
128
125
140
201
295
225
97
103
178
663
30
34
346
90
84
232
187
-131
191
173
133
149
-148
-75
-28
8
-49
110
41
135
136
-18
189
142
214
209
215
206
Operating Profit %
11 %
3 %
7 %
13 %
8 %
14 %
16 %
17 %
15 %
10 %
11 %
16 %
10 %
5 %
5 %
10 %
7 %
11 %
15 %
22 %
-25 %
17 %
17 %
14 %
15 %
-23 %
-13 %
-5 %
-9 %
-7 %
6 %
-3 %
11 %
14 %
-5 %
12 %
15 %
19 %
15 %
18 %
16 %
Depreciation
20
32
36
40
39
42
44
31
38
35
37
38
44
29
31
28
30
43
42
44
45
49
53
53
52
55
57
61
61
60
62
60
61
60
60
49
48
49
49
48
49
Interest
15
28
34
54
62
56
58
44
48
52
49
50
46
17
17
22
23
35
40
40
40
37
37
35
42
42
44
42
50
55
68
58
81
76
79
70
71
80
74
52
50
Profit Before Tax
33
19
69
68
24
41
98
220
140
10
17
90
573
-16
-14
296
37
6
149
104
-217
105
83
46
55
-244
-175
-131
-103
-163
-20
-78
-7
0
-157
70
23
85
86
114
106
Tax
22
9
34
10
20
9
13
24
8
4
5
2
-5
-14
-6
-0
-8
3
7
11
-11
3
6
11
12
-36
-7
-5
-132
-28
-38
4
7
10
-7
16
13
17
14
24
21
Net Profit
11
10
35
58
4
33
85
196
132
6
12
88
578
-3
-9
296
45
3
142
92
-207
102
77
35
44
-209
-168
-127
29
-135
19
-82
-14
-9
-150
54
10
68
72
90
86
EPS in ₹
1.91
1.34
4.44
6.59
1.74
2.91
8.29
20.96
12.57
0.06
0.96
9.55
63.56
-0.48
-1.34
32.77
5.31
0.41
15.94
10.48
-22.77
11.56
9.03
4.22
5.14
-22.88
-18.12
-13.55
3.25
-15.13
2.54
-8.86
-1.06
-0.79
-14.54
5.43
1.98
7.64
7.81
9.56
8.92
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
2,475
7,659
8,105
6,708
7,980
6,152
7,015
6,976
6,638
5,840
Fixed Assets
701
2,499
2,980
2,977
3,648
2,099
2,219
2,347
2,311
1,865
Current Assets
1,429
3,595
3,792
2,484
3,049
2,372
2,817
3,362
3,243
2,969
Capital Work in Progress
171
1,200
780
620
453
413
447
291
151
162
Investments
561
1,260
1,525
588
702
549
697
540
490
303
Other Assets
1,041
2,700
2,821
2,524
3,177
3,091
3,651
3,798
3,687
3,510
Total Liabilities
2,475
7,659
8,105
6,708
7,980
6,152
7,015
6,976
6,638
5,840
Current Liabilities
1,020
1,940
3,104
1,899
2,662
2,545
2,738
3,412
2,990
2,879
Non Current Liabilities
291
2,813
2,119
2,191
2,516
1,012
1,463
1,181
1,475
889
Total Equity
1,164
2,906
2,882
2,618
2,802
2,595
2,814
2,383
2,173
2,072
Reserve & Surplus
1,085
2,774
2,659
2,374
2,559
2,438
2,687
2,269
2,105
2,034
Share Capital
60
89
89
90
90
90
90
90
90
92
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-288
812
-596
-259
110
-184
-56
45
133
-143
Investing Activities
50
-2,205
-1,222
570
-145
1,321
-522
-119
302
-150
Operating Activities
83
73
288
187
60
205
481
-258
44
701
Financing Activities
-421
2,944
338
-1,016
194
-1,709
-16
421
-214
-693
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
29.67 %
29.62 %
29.60 %
29.60 %
30.60 %
30.37 %
31.07 %
30.89 %
28.27 %
28.07 %
27.78 %
27.39 %
25.88 %
25.86 %
25.84 %
26.82 %
28.30 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.05 %
0.05 %
0.05 %
0.05 %
0.00 %
0.00 %
24.57 %
26.71 %
30.08 %
28.48 %
28.32 %
DIIs
14.82 %
13.23 %
14.22 %
14.85 %
12.40 %
9.82 %
13.59 %
18.84 %
18.29 %
20.00 %
18.22 %
17.56 %
18.04 %
18.56 %
18.24 %
16.92 %
13.72 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
Public / Retail
14.01 %
16.64 %
17.89 %
20.42 %
21.82 %
22.29 %
22.40 %
22.43 %
25.51 %
24.93 %
23.39 %
22.65 %
21.19 %
20.87 %
18.57 %
20.86 %
21.52 %
Others
41.49 %
40.51 %
38.29 %
35.12 %
35.19 %
37.51 %
32.88 %
27.77 %
27.86 %
26.93 %
30.60 %
32.39 %
10.32 %
8.00 %
7.26 %
6.90 %
8.14 %
No of Share Holders
74,074
96,976
1,06,927
1,25,553
1,33,190
1,34,718
1,30,682
1,23,964
1,20,916
1,12,775
1,01,638
91,182
84,695
91,917
96,009
1,14,236
95,125

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 4.5 2 3 0.00 0.00 0.00 0.00 2.5 0.00
Dividend Yield (%) 0.00 0.69 0.42 0.93 0.00 0.00 0.00 0.00 0.37 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
22 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 22 May 2025 663.35 694.95
30 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 30 Jan 2025 628.20 608.70
24 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 24 Oct 2024 720.09 683.70
25 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 25 Sept 2024 597.53 611.51
10 Sept 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
 10 Sept 2024 488.59 572.84
09 Sept 2024 DIVIDEND Dividend
₹ 2.50 /share
 09 Sept 2024 370.78 595.84
28 Aug 2023 ANNUAL GENERAL MEETING Annual General Meeting
NA
 28 Aug 2023 193.07 192.90
04 Aug 2023 DIVIDEND Dividend
₹ 1.50 /share
 04 Aug 2023 165.46 194.41
06 Aug 2021 DIVIDEND Dividend
₹ 2.50 /share
 05 Aug 2021 356.19 342.54
18 Jul 2018 CHANGE OF NAME Change Of Name
NA
 18 Jul 2018 157.75 157.75

Announcements

Closure of Trading Window4 days ago
Intimation Pursuant To Regulation 31A4 days ago
Announcement under Regulation 30 (LODR)-RestructuringJun 16, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 27, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
Intimation Pursuant To Regulation 31A Of The Sebl (Listing Obligations And Disclosure Requirements) Regulations 2015 Regarding Promoter ReclassificationMay 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 22, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On May 22 2025May 22, 2025
Update On Promoters Reclassification RequestMay 22, 2025
Appointment Of Secretarial AuditorMay 22, 2025
Corporate Action-Board approves DividendMay 22, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 22, 2025
Outcome Of Board Meeting Of The Company Held On May 22 2025May 22, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementMay 15, 2025
Intimation Under Regulation 31A Of SEBI Listing RegulationsMay 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 15, 2025
Board Meeting Intimation for Intimation On Board MeetingMay 15, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 10, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 30, 2025
Strides Acquires Identified Andas From Nostrum Laboratories Inc. USAApr 29, 2025
Announcement under Regulation 30 (LODR)-AcquisitionApr 11, 2025
Intimation For Change In Details Of Key Managerial Personnel For Determining Materiality Of Events Or Information And Making Disclosure To Stock Exchange Under Regulation 30 Of SEBI Listing RegulationsApr 03, 2025
Update On Redemption Of Secured Unlisted Redeemable Non-Convertible DebenturesApr 01, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMar 21, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 21, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMar 19, 2025
Proposed De-Merger Of Identified Business Of Arco Lab Private Limited (Arco Lab) A Wholly Owned Subsidiary Of The CompanyMar 19, 2025
DissolutionMar 18, 2025
Announcement under Regulation 30 (LODR)-AcquisitionMar 14, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 18, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 30, 2025
Integrated Filing (Financial)Jan 30, 2025
Announcement under Regulation 30 (LODR)-Change in Registered Office AddressJan 30, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateJan 30, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 30, 2025
Board Meeting Outcome for Outcome Of Board Meeting - Un-Audited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended December 31 2024Jan 30, 2025
Outcome Of Board Meeting - Un-Audited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended December 31 2024Jan 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 24, 2025
Board Meeting Intimation for Announcement Of Board Meeting Under Regulation 29 Of SEBI Listing RegulationsJan 24, 2025
Onesource Specialty Pharma Limited (Onesource) - IndiaS First Specialty Pharma CDMO Receives Listing And Trading Approval For Its Equity Shares From BSE And NSE. Onesource To Start Trading In NSE Jan 23, 2025
Strides Pharma Debuts With A Stellar ESG Rating Of 76/100 In The S&P Globals Corporate Sustainability Assessment (CSA) 2024Jan 22, 2025
Intimation About Receipt Of Order On Jan 20 2024 From The Transfer Pricing Officer Being Issued Under Section 92 CA (3) Of Income Tax Act 1961 For AY 22-23Jan 21, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 20, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 27, 2024

Technical Indicators

RSI(14)
Neutral
69.73
ATR(14)
Volatile
35.79
STOCH(9,6)
Neutral
75.80
STOCH RSI(14)
Neutral
59.78
MACD(12,26)
Bearish
-0.07
ADX(14)
Strong Trend
45.04
UO(9)
Bearish
61.33
ROC(12)
Uptrend But Slowing Down
1.95
WillR(14)
Overbought
-13.65
Bearish
4
Neutral
4
Bullish
1

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan Small Cap Fund Direct-Growth
0.62%
-49087
0.02%
0.04%
Samco Multi Cap Fund Direct-Growth
0.36%
16088
0.36%
0.36%
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
1.39%
13353
0.51%
0.31%
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth
0.72%
12306
0.07%
0.04%
JM Small Cap Fund Direct - Growth
1.24%
-8000
0.02%
-0.45%
Groww Nifty Total Market Index Fund Direct - Growth
0.03%
12
0.00%
0.00%
Angel One Nifty Total Market Index Fund Direct - Growth
0.03%
8
0.00%
0.00%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.03%
3
0.00%
0.00%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.43%
2
0.08%
0.07%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.03%
1
0.01%
0.01%
ITI Pharma and Healthcare Fund Direct - Growth
1.01%
0
0.19%
0.15%
Mirae Asset Flexi Cap Fund Direct - Growth
0.00%
0
0.00%
0.00%
Axis Small Cap Fund Direct-Growth
0.24%
0
0.03%
0.02%
Axis Value Fund Direct-Growth
0.00%
0
0.00%
0.00%
Axis Equity Savings Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Midcap Fund Direct-Growth
0.22%
0
0.03%
0.01%
Axis Business Cycles Fund Direct-Growth
0.00%
0
0.00%
0.00%
Aditya Birla Sun Life Value Direct Fund-Growth
0.79%
0
0.12%
0.09%
Aditya Birla Sun Life Special Opportunities Fund Direct-Growth
0.00%
0
0.00%
0.00%
ITI Large & Mid Cap Fund Direct-Growth
0.00%
0
0.00%
-0.45%
Aditya Birla Sun Life Flexi Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
JM ELSS Tax Saver Fund Direct Plan-Growth
0.00%
0
0.00%
-1.40%
JM Flexicap Fund Direct Plan-Growth
0.00%
0
0.00%
0.00%
JM Midcap Fund Direct - Growth
0.00%
0
0.00%
0.00%
Aditya Birla Sun Life Retirement Fund - The 50s Plan Direct-Growth
0.00%
0
0.00%
0.00%
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Technical Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2025 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104